Call Options

15 transactions
Quarter Operation Price Per call calls change calls Held SEC Form
Q3 2024

Nov 14, 2024

BUY
$10.32 - $12.13 $412,800 - $485,200
40,000 Added 8.71%
499,000 $5.79 Million
Q2 2024

Aug 14, 2024

SELL
$10.05 - $12.02 $1.3 Million - $1.55 Million
-129,000 Reduced 21.94%
459,000 $4.88 Million
Q1 2024

May 15, 2024

SELL
$11.27 - $13.53 $1.45 Million - $1.74 Million
-128,500 Reduced 17.93%
588,000 $7.02 Million
Q4 2023

Feb 14, 2024

BUY
$8.77 - $10.85 $2.42 Million - $3 Million
276,400 Added 62.8%
716,500 $7.76 Million
Q3 2023

Nov 14, 2023

BUY
$9.59 - $11.35 $1.96 Million - $2.32 Million
204,000 Added 86.4%
440,100 $4.34 Million
Q2 2023

Aug 14, 2023

BUY
$9.02 - $10.29 $1.53 Million - $1.75 Million
170,000 Added 257.19%
236,100 $2.36 Million
Q1 2023

May 15, 2023

SELL
$9.2 - $12.26 $4.47 Million - $5.96 Million
-486,200 Reduced 88.03%
66,100 $635,000
Q4 2022

Feb 14, 2023

SELL
$8.72 - $11.56 $626,096 - $830,008
-71,800 Reduced 11.5%
552,300 $6.15 Million
Q3 2022

Nov 14, 2022

BUY
$8.48 - $11.13 $4.09 Million - $5.37 Million
482,200 Added 339.82%
624,100 $5.32 Million
Q2 2022

Aug 15, 2022

SELL
$9.95 - $12.27 $1.84 Million - $2.27 Million
-185,300 Reduced 56.63%
141,900 $1.49 Million
Q1 2022

May 16, 2022

BUY
$9.81 - $15.4 $1.34 Million - $2.11 Million
136,900 Added 71.94%
327,200 $3.56 Million
Q4 2021

Feb 14, 2022

SELL
$12.09 - $14.68 $895,869 - $1.09 Million
-74,100 Reduced 28.03%
190,300 $2.58 Million
Q3 2021

Nov 15, 2021

BUY
$13.25 - $15.13 $577,700 - $659,668
43,600 Added 19.75%
264,400 $3.58 Million
Q1 2021

May 17, 2021

BUY
$13.59 - $18.54 $2.32 Million - $3.17 Million
170,800 Added 341.6%
220,800 $3.09 Million
Q4 2020

Feb 16, 2021

BUY
$14.3 - $18.74 $715,000 - $936,999
50,000 New
50,000 $937,000

Others Institutions Holding VTRS

About Viatris Inc


  • Ticker VTRS
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 1,212,669,952
  • Market Cap $15.8B
  • Description
  • Viatris Inc. operates as a healthcare company worldwide. The company operates in four segments: Developed Markets, Greater China, JANZ, and Emerging Markets. It offers prescription brand drugs, generic drugs, complex generic drugs, biosimilars, and active pharmaceutical ingredients (APIs). The company offers drugs in various therapeutic areas, i...
More about VTRS
Track This Portfolio

Track Continental Advisors LLC Portfolio

Follow Continental Advisors LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Continental Advisors LLC, based on Form 13F filings with the SEC.

News

Stay updated on Continental Advisors LLC with notifications on news.